Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Use of Reverse Phase Protein Microarrays and Reference Standard Development for Molecular Network Analysis of Metastatic Ovarian Carcinoma

30 Jan 2005

Abstract excerpt

Cancer can be defined as a deregulation or hyperactivity in the ongoing network of intracellular and extracellular signaling events. Reverse phase protein microarray technology may offer a new opportunity to measure and profile these signaling pathways, providing data on post-translational phosphorylation events not obtainable by gene microarray analysis. Treatment of ovarian epithelial carcinoma almost always...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced Biosensing Techniques and Applications
Share to Advanced Proteomics Techniques and Applications
Share to Monoclonal and Polyclonal Antibodies Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 15671044
DOI: 10.1074/mcp.t500003-mcp200

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Use of Reverse Phase Protein Microarrays and Reference Standard Development for Molecular Network Analysis of Metastatic Ovarian CarcinomaPMID 15671044Read ↗

Reverse-phase protein microarrays: application to biomarker discovery and translational medicineSemantic proximity Read ↗

Reverse phase protein microarrays advance to use in clinical trialsSemantic proximity Read ↗

Protein microarrays: Molecular profiling technologies for clinical specimensSemantic proximity Read ↗

Proteomic strategies and challenges in tumor metastasis researchSemantic proximity Read ↗

Monitoring proteins and protein networks using reverse phase protein arrays.Semantic proximity Read ↗

Mapping Molecular Networks Using Proteomics: A Vision for Patient-Tailored Combination TherapySemantic proximity Read ↗

A Reverse Phase Protein Array Based Phospho-antibody Characterization Approach and Its Applicability for Clinical Derived Tissue SpecimensSemantic proximity Read ↗

A comparative phosphoproteomic analysis of a human tumor metastasis model using a label-free quantitative approach.Semantic proximity Read ↗

Pathology of the Future: Molecular Profiling for Targeted TherapySemantic proximity Read ↗

Signal pathway profiling of ovarian cancer from human tissue specimens using reverse‐phase protein microarraysSemantic proximity Read ↗

Identification of metastasis-associated proteins in a human tumor metastasis model using the mass-mapping technique.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.